PRKDC and colorectal carcinoma: Upon inhibiting miR-375 expression, the suppressive roles of circ-PRKDC interference in drug resistance were weakened, indicating that circ-PRKDC facilitated 5-FU resistance in CRC by modulating miR-375, which also interacted with FOXM1.